{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 1,
        "evidence": "A 6-patient pilot study was conducted in women undergoing sentinel lymph node (SLN) mapping for breast cancer."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Subjects received 99m Tc-sulfur colloid lymphoscintigraphy. In addition, 12.5 \u00b5g of indocyanine green (ICG) diluted in human serum albumin (HSA) was used as an NIR fluorescent lymphatic tracer."
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A 6-patient pilot study was conducted"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 1,
        "evidence": "In the pilot clinical trial, a total of 9 SLNs were identified by 99m Tc-lymphoscintigraphy and 9 SLNs were identified by NIR fluorescence, although results differed in two patients."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were encountered."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 6,
    "max_score": 25
  },
  "model": "gpt-4o"
}